Biogen Idec is a global pharmaceutical corporation based in San Diego, CA, that specializes in the discovery, development, manufacturing, and commercialization of innovative therapies for diseases with high unmet medical needs. With a history dating back to 1978, Biogen Idec is recognized as a leader in the field, offering a range of significant products that address conditions such as lymphoma, multiple sclerosis, and rheumatoid arthritis, benefiting patients in over 90 countries.
Driven by a strong corporate strategy and goals, Biogen Idec focuses on product development, engineering science, and global quality to create new standards of care. With a commitment to improving patients' lives, the company's dedication to innovation and its global reach have contributed to its significant growth, with total revenues reaching almost $3.2 billion in 2007.
Generated from the website